ASCO 2018

Area: Oncology

Location: Chicago, United States

Date: June 1 to June 5

Description:

American Society of Clinical Oncology.


Search in Scientific Content:
Date
Filters:
Molecular
10:07

Molecular evolution in breast cancer

Presenter: Lajos Pusztai
Oncology
Novelties
10:22

Novelties in melanoma treatment at ASCO 2018

Presenter: Paolo A. Ascierto
Oncology
Immunother
11:02

Immunotherapy in SCLC

Presenter: Taofeek Kunle Owonikoko
Oncology
PROPHECY t
5:39

PROPHECY trial: circulating tumor cell AR-V7 detection in mCRPC receiving abiraterone or enzalutamide

Presenter: Andrew J. Armstrong
Oncology
State of a
20:11

State of art NET treatment in 2018

Presenter: Nicola Fazio
Oncology
Cabozatini
4:51

Cabozatinib vs sunitinib in advanced RCC PROPHECY trial: circulating tumor cell AR-V7 detection in mCRPC receiving abiraterone or enzalutamide

Presenter: Ronald C. Chen
Oncology
Immunother
8:05

Immunotherapy in colorectal cancer

Presenter: Michael Overman
Oncology
How do I t
5:07

How do I treat early relapsed follicular lymphoma?

Presenter: Jonathan W. Friedberg
Oncology
Treating s
3:44

Treating sarcoma in elderly patients

Presenter: Mark Agulnik
Oncology
VALENTINO
3:13

VALENTINO study: panitumumab maintenance therapy in RAS WT metastatic colorectal cancer

Presenter: Filippo Pietrantonio
Oncology
Cabozantin
8:40

Cabozantinib alone or in combination with trastuzumab in breast cancer with brain metastases

Presenter: Jose Pablo Leone
Oncology
ALEX Study
8:31

ALEX Study: alectinib vs crizotinib in untreated advanced ALK+ NSCLC 23

Presenter: D. Ross Camidge
Oncology
Phase 2 st
6:20

Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma

Presenter: Luciano J. Costa
Oncology
Tepotinib
2:53

Tepotinib in patients with advanced NSCLC harboring MET exon 14-skipping mutations

Presenter: Enriqueta Felip
Oncology
KEYNOTE-00
2:53

KEYNOTE-001 trial: 4-year OS for patients with advanced NSCLC

Presenter: Enriqueta Felip
Oncology
Update on
3:54

Update on KEYNOTE-052: first-line pembrolizumab in cisplatin-ineligible advanced urothelial cancer

Presenter: Jacqueline Vuky
Oncology

EADO 2019

2019-04-24 - 2019-04-27
Paris, France

BCC 2019

2019-03-20 - 2018-03-23
Vienna, Austria

SABCS 2018

2018-12-04 - 2018-12-08
San Antonio, United States

ESMO 2018

2018-10-19 - 2018-10-23
Munich, Germany

ECCO 2018

2018-02-14 - 2018-02-17
Vienna, Austria

SABCS 2017

2017-12-05 - 2017-12-09
San Antonio, United States

ESMO 2017

2017-09-08 - 2017-09-12
Madrid, Spain

ICML 2017

2017-06-14 - 2017-06-17
Lugano, Switzerland

ASCO 2017

2017-06-02 - 2017-06-06
Chicago, United States